BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 26392377)

  • 1. The role of the transcription factor Ets1 in carcinoma.
    Dittmer J
    Semin Cancer Biol; 2015 Dec; 35():20-38. PubMed ID: 26392377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells.
    Rodgers JJ; McClure R; Epis MR; Cohen RJ; Leedman PJ; Harvey JM; ; Thomas MA; Bentel JM
    J Cell Biochem; 2019 Jan; 120(1):848-860. PubMed ID: 30161276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ets1 and ESE1 reciprocally regulate expression of ZEB1/ZEB2, dependent on ERK1/2 activity, in breast cancer cells.
    Sinh ND; Endo K; Miyazawa K; Saitoh M
    Cancer Sci; 2017 May; 108(5):952-960. PubMed ID: 28247944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ETS1 is coexpressed with ZEB2 and mediates ZEB2-induced epithelial-mesenchymal transition in human tumors.
    Yalim-Camci I; Balcik-Ercin P; Cetin M; Odabas G; Tokay N; Sayan AE; Yagci T
    Mol Carcinog; 2019 Jun; 58(6):1068-1081. PubMed ID: 30790340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of an intramolecular protein-protein interaction in c-Ets1 and its viral homologue v-Ets.
    Schmidt M; Schmidt AM; Dietl J; Kammerer U
    Oncol Rep; 2007 Aug; 18(2):457-63. PubMed ID: 17611671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dissection of the oncogenic role of ETS1 in the mesenchymal subtypes of head and neck squamous cell carcinoma.
    Gluck C; Glathar A; Tsompana M; Nowak N; Garrett-Sinha LA; Buck MJ; Sinha S
    PLoS Genet; 2019 Jul; 15(7):e1008250. PubMed ID: 31306413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [How tumors abuse their host: the transcription factor c-ets1 and the regulation of tumor angiogenesis or invasion].
    Vandenbunder B; Wernert N; Stéhelin D
    Contracept Fertil Sex; 1994 Oct; 22(10):656-60. PubMed ID: 7528601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF9-induced ovarian cancer cell invasion involves VEGF-A/VEGFR2 augmentation by virtue of ETS1 upregulation and metabolic reprogramming.
    Bhattacharya R; Ray Chaudhuri S; Roy SS
    J Cell Biochem; 2018 Nov; 119(10):8174-8189. PubMed ID: 29904943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistant breast cancer cells overexpress ETS1 gene.
    Kars MD; Işeri OD; Gündüz U
    Biomed Pharmacother; 2010 Sep; 64(7):458-62. PubMed ID: 20392592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative role of acetylation along c-SRC/ETS1 signaling pathway in bone metastatic and invasive mammary cell phenotypes.
    Bendinelli P; Maroni P; Matteucci E; Desiderio MA
    Biochim Biophys Acta; 2011 Oct; 1813(10):1767-76. PubMed ID: 21741415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-377 functions as a tumor suppressor in human clear cell renal cell carcinoma by targeting ETS1.
    Wang R; Ma Y; Yu D; Zhao J; Ma P
    Biomed Pharmacother; 2015 Mar; 70():64-71. PubMed ID: 25776481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen synthase kinase-3 beta (GSK3β)-mediated phosphorylation of ETS1 promotes progression of ovarian carcinoma.
    Tsai CL; Jung SM; Chi LM; Tsai CN; Lin CY; Chao A; Lee YS
    Aging (Albany NY); 2021 May; 13(10):13739-13763. PubMed ID: 34023818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biology of the Ets1 proto-oncogene.
    Dittmer J
    Mol Cancer; 2003 Aug; 2():29. PubMed ID: 12971829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncovering a Key Role of ETS1 on Vascular Abnormality in Glioblastoma.
    Tang J; Li Y; Liu B; Liang W; Hu S; Shi M; Zeng J; Li M; Huang M
    Pathol Oncol Res; 2021; 27():1609997. PubMed ID: 34867089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ETS1 promotes chemoresistance and invasion of paclitaxel-resistant, hormone-refractory PC3 prostate cancer cells by up-regulating MDR1 and MMP9 expression.
    Kato T; Fujita Y; Nakane K; Kojima T; Nozawa Y; Deguchi T; Ito M
    Biochem Biophys Res Commun; 2012 Jan; 417(3):966-71. PubMed ID: 22206665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ras signaling requires dynamic properties of Ets1 for phosphorylation-enhanced binding to coactivator CBP.
    Nelson ML; Kang HS; Lee GM; Blaszczak AG; Lau DK; McIntosh LP; Graves BJ
    Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10026-31. PubMed ID: 20534573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of ets1 proto-oncogene for breast cancer progression.
    Dittmer J; Vetter M; Blumenthal SG; Lindemann RK; Kölbl H
    Zentralbl Gynakol; 2004 Aug; 126(4):269-71. PubMed ID: 15389378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Role for Autoinhibition in Preventing Dimerization of the Transcription Factor ETS1.
    Samorodnitsky D; Szyjka C; Koudelka GB
    J Biol Chem; 2015 Sep; 290(36):22101-10. PubMed ID: 26195629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ets1 associates with KMT5A to participate in high glucose-mediated EndMT via upregulation of PFN2 expression in diabetic nephropathy.
    Lu L; Zhong Z; Gu J; Nan K; Zhu M; Miao C
    Mol Med; 2021 Jul; 27(1):74. PubMed ID: 34238215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2.
    Plotnik JP; Hollenhorst PC
    Nucleic Acids Res; 2017 May; 45(8):4452-4462. PubMed ID: 28119415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.